Health · Public Health & Disease · 5 hrs ago
South Korea to start COVID vaccinations for high-risk children on Nov. 11
South Korea will start COVID-19 vaccinations for high-risk children on Nov.
11.
The programme covers children aged 6 months to 11 years, including those with weakened immune systems and residents of facilities for people vulnerable to infection.
The shots were brought in urgently because no COVID-19 vaccine for children under 12 is approved in South Korea.
Children who have not finished their initial course need one or two doses, while those who have completed it should get one dose each year, or two if they are immunocompromised.
The programme will run through April 30, 2027, and families can check the national vaccination website for participating clinics.
Caregivers must bring documents confirming eligibility, and children should remain at the clinic for 20 to 30 minutes after vaccination to be observed.
The campaign is intended to protect children at higher risk of severe illness during winter.
South Korea will begin COVID-19 vaccinations for high-risk children and infants aged 6 months to 11 years on Nov. 11.
The national vaccination program is scheduled to continue through April 30, 2027.
The vaccine was brought in on an emergency basis because no COVID-19 vaccine is licensed or approved in South Korea for children under 12.
Eligible children include those with weakened immune systems and those living in or admitted to facilities for people vulnerable to infection.
Children who have not completed their initial vaccination series must receive one or two doses, while those who have completed it should receive one dose each year, or two doses if immunocompromised.
- Who
- High-risk children and infants aged 6 months to 11 years in South Korea.
- What
- A national COVID-19 vaccination program will begin for them.
- When
- Nov. 11; the program runs through April 30, 2027.
- Where
- South Korea. Eligible vaccination facilities can be found on the KDCA vaccination website.
- Why
- To protect high-risk children and infants; no COVID-19 vaccine is licensed or approved in South Korea for children under 12.
This story does not have two clearly opposing sides.
The Korea Disease Control and Prevention Agency announced the vaccination program.
Vaccinations are scheduled to begin for high-risk children and infants.
The vaccination program is scheduled to end.
- Eligible age
- 6 months to 11 years
- Program start
- Nov. 11
- Program end
- April 30, 2027
- Initial series
- 1–2 doses
- Annual doses after initial series
- 1 dose; 2 for immunocompromised children
1 source
What people are saying
I ask guardians to actively participate in vaccination so that children and infants at high risk of severe illness can safely get through the winter.